A.M. Pappas Life Science Ventures raises $85.7M fund

Posted by on Jan 17, 2019 in Newsroom | 0 comments

DURHAM, N.C. – Pappas Life Science Ventures has raised a new $85.7 million investment fund, according to a regulatory filing. Arthur M. Pappas, better known as “Art,” has focused on life science investing as managing partner at Pappas Capital for 25 years. The products Pappas-backed companies have brought to market – for treating such conditions as melanoma, ovarian cancer, and hemophilia, have been used throughout the world to treat tens of thousands of patients and account for billions of dollars of revenue. Pappas received the CED Life Science Leadership Award in 2017 and...

Read More

Locus and Janssen Ink Potential $818 Million Deal to Develop CRISPR-Based Antibacterials

Posted by on Jan 7, 2019 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. – Locus Biosciences, inked a collaboration and license deal with Janssen Pharmaceutical, a Johnson & Johnson company. The companies will work to develop precision antibacterial therapies based on CRISPR-Cas3-enhanced bacteriophage. Under the terms of the deal, Janssen is paying Locus $20 million up front. Locus will be eligible for up to a total of $798 million in development and commercial milestones, as well as royalties on any product sales. Locus focuses on using Type 1 CRISPR-Cas3 to degrade the DNA of target bacteria, which quickly kills...

Read More

Virginia Bio Welcomes New Members to its Board of Directors

Posted by on Jan 7, 2019 in Newsroom | 0 comments

RICHMOND, VA. – Virginia Bio, the premier statewide non-profit association representing the life science industry in Virginia, has elected five new members to their Board of Directors for a term of three years beginning January 1. The newly elected directors are: Robert Day, COO, TECHLAB, Inc., Blacksburg; Kolaleh Eskandanian, VP and Chief Innovation Officer Children’s National Health System; Mark Gignac, Executive Director, Institute for Advanced Learning and Research (IALR); Michael Perham, Director, Innovations and External Relations, HHMI Janelia Research Campus; and Denise Toney,...

Read More

5 Biopharma Trends to Watch in 2019

Posted by on Jan 2, 2019 in Newsroom | 0 comments

“If you can look into the seeds of time, and say which grain will grow and which will not, speak then unto me,” Banquo beseeches the witches in Shakespeare’s “Macbeth,” seeking insight into the future for himself and his closest friend Macbeth. Biopharma industry watchers, executives, and especially investors often display that same desire as a year comes to a close, which explains why there’s typically a wave of news articles and commentaries attempting to divine events of the coming year based on the 12 months that are coming to a close. 2018 saw several first-in-class...

Read More

These 10 VC Firms Made The Most Investments In Healthcare Startups This Year

Posted by on Jan 2, 2019 in Newsroom | 0 comments

To those who have been following the space, it’s no surprise that 2018 has been a record year for venture capital investing in healthcare. With $28.8 billion raised through the end of November (and big deals like the $400 million Series C raised by Relay Therapeutics last week) startups in the sector have raised more money this year than any year before in the last 10 years that VC funding database Pitchbook has tracked investments in the space. “In spite of market volatility, the potential curative impact of many of the breakthroughs this year continues to be the driver of long-term...

Read More